Reimbursement for ARISTADA® (aripiprazole lauroxil) may depend on several factors. Place of service, type of payer, and benefit category are the 3 main considerations that affect coverage and reimbursement for treatment with ARISTADA. In some situations, a prior authorization (PA) may be needed for ARISTADA. To learn more, download the reimbursement guide by clicking below.
This is not a guarantee of payment, coverage, or reimbursement. Alkermes does not provide any advice, recommendation, guarantee, or warranty relating to coverage, reimbursement, or coding for any product or service. Healthcare providers are responsible for determining coverage and reimbursement information and ensuring the accuracy and completeness of claim submissions for their patients. Coding, coverage, and reimbursement vary significantly by payer, patient, and setting of care and are subject to change. Additional information may exist. Actual coverage and reimbursement decisions are made by individual payers.
|Procedures, services, or supplies (eg, HCPCS code)|
|Procedures, services, or supplies (eg, NDCs)|
|Procedures, services, or supplies (eg, CPT® code†)||96372 therapeutic, prophylactic, diagnostic injection‡|
|Diagnosis or nature of illness or injury|
CPT®=Current Procedural Terminology. CPT® is a registered trademark of the American Medical Association.
*All examples indicated should also include any placeholder digits required by the 837P format.
†This code is not intended to be reported by the physician in the facility setting.
‡ARISTADA is administered as an IM injection only.